Registration Call for MarketsandMarkets™ 4th Annual Next Gen Microbiome and Probiotics Conference

2022-06-15
合作
Know about new microbiome findings, branding, and marketing of probiotics, effective translation from R&D to commercialization
CHICAGO, June 15, 2022 /PRNewswire/ -- The ecology of human microbiome is known to be associated with both phenotype and environment. With the increasing focus on the development of human microbiome therapies and probiotics product and drug development, various small innovative players are operating in the market. However, inadequate research and regulatory policies in the human microbiome are some of the factors which restrain the progress.
The 4th Annual Next Gen Microbiome and Probiotics Conference which will be held on 16th-17th June 2022 at Double Tree by Hilton – Mission Valley, San Diego, USA, will give the attendees an opportunity to connect with biotech, pharma, academicians, and investors, discussing the most ingenious research and technological advances. They will also get access to some interesting key sessions on applying new microbiome findings, regulatory updates, branding, and marketing of probiotics along with discussion on effective translation from R&D to commercialization.
This event will bring together professionals in healthcare, therapeutics, universities, researchers, and scientists to discuss cutting-edge developments in microbiome and probiotics.
Featured Speakers:
Julius Goepp, Founder, CEO,
Scaled Microbiomics
Emily Stein, CEO,
Nicole M. Scott, CEO and Founder,
Yug Varma, CEO,
Maya Ivanjesku, Chief Scientific Officer,
Seth D. Crosby, Director, Research Collaborations,
Oliver Worsley, CEO,
Sequential Skin
Larry Weiss, CEO & Founder,
Symbiome
Sandrine Miller-Montgomery, Co-Founder, President and CEO,
Micronoma
Registration link - https://events.marketsandmarkets.com/4th-annual-marketsandmarkets-next-gen-microbiome-and-probiotics-conference/register
About MarketsandMarkets™
MarketsandMarkets™ is a revenue impact and advisory firm, providing quantified B2B research to over 10,000 clients worldwide. Built on the 'GIVE Growth' principle, we work with several Forbes Global 2000 B2B companies - helping them stay relevant in a disruptive ecosystem - by providing actionable insights on disruptive trends and identifying blind spots, assessing competitive landscape in real-time, and analyzing how these trends are impacting not only customers but also their customers as well. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research.
To find out more, visit www.MarketsandMarkets.com or follow us on Twitter, LinkedIn and Facebook.
For further insights, contact:
Charu Raizada
MarketsandMarkets™ INC.
Email: [email protected]
USA: +1-888-600-6441
Visit Our Website: https://www.MarketsandMarkets.com
Logo: https://mma.prnewswire.com/media/660509/MarketsandMarkets_Logo.jpg
SOURCE MarketsandMarkets
更多内容,请访问原始网站
文中所述内容并不反映新药情报库及其所属公司任何意见及观点,如有版权侵扰或错误之处,请及时联系我们,我们会在24小时内配合处理。
适应症
-
靶点
-
药物
-
来和芽仔聊天吧
立即开始免费试用!
智慧芽新药情报库是智慧芽专为生命科学人士构建的基于AI的创新药情报平台,助您全方位提升您的研发与决策效率。
立即开始数据试用!
智慧芽新药库数据也通过智慧芽数据服务平台,以API或者数据包形式对外开放,助您更加充分利用智慧芽新药情报信息。